Bio-start Selects First Cohort: 15 companies join Bio-start’s inaugural synthetic biology accelerator
- Posted on 20 February, 2017
Bio-start is pleased to announce the 15 companies that will be joining the UK’s first synthetic biology accelerator programme. Applicants from across the UK have applied for entry into the 10-week intensive programme of high-quality mentorship, entrepreneurial training & workshops, with access to a global network of customers and opportunities. The selected companies will enjoy unique access to an experienced group of mentors and sector specific experts to help them navigate the many challenges faced by early stage companies.
The programme begins on Wednesday the 22nd February and will culminate 10 weeks later with an award ceremony in London. The finalist from the programme will pitch in front of selected judges and invited audience. The judges, led by Sir Richard Sykes, will announce the winners. Bio-start will reward the companies judged to be the startups with the most robust business model and capable of delivering the highest impact with equity-free cash awards, professional services and free-laboratory space at locations across the UK. Bio-start is proud to recognize its sponsors: SynbiCITE, Rainbow Seed Fund, Cambridge Consultants, Imperial Innovations, Analytik-Jena, BioCity,UnitDX Science Incubator, Norwick Research Park, Keltie and Twist Biosciences. For further information on sponsorship opportunities please contact: email@example.com
The companies selected to take part in Bio-start reflect the unique diversity present in one of the most exciting and innovative startup sectors in the UK. All the companies are deploying engineering biology to deliver transformation across many different applications and sectors. The companies in the first Bio-start cohort include startups from England, Scotland and Ireland and spinouts from Birmingham, Bristol, Cambridge, Imperial College, Newcastle and Oxford Universities.
We are excited to welcome all the companies selected to Bio-start and look forward to keeping you updated on their progress.
Kick-off starts Wednesday the 22nd February. If you want attend the event please register: https://www.eventbrite.co.uk/e/bio-start-kick-off-tickets-31993934720
|Colorifix||Eco-friendly, sustainable, biologically derived textile dyes|
|Customem||Bio-filtration of micro-pollutants found in industrial waste|
|Biotangents||Rapid diagnostic tests for critical animal healthcare|
|Entomics Biosystems||High value bio-products from food waste|
|EnzBond||Novel biocatalysts for chemical production|
|Essential Diagnostics||Accessible point of care testing for infections|
|Helixworks Technologies||Molecular DNA data storage|
|IDRIS||Bio-design of novel diagnostics and therapeutic antibodies|
|Linear Diagnostics||Diagnostic tests for antimicrobial resistant strains|
|Nuclera Nucleics||DNA synthesis|
|Phytoform Labs||Horticultural plant breeding|
|Quethera||Gene therapy for critical unmet medical needs|
|VideraBio||Harnessing the productivity of microbial cell factories|
Share this article:
People also read
The SynbiCITE ‘4-Day MBA, More Business Acumen’ Course
The SynbiCITE ‘4-Day MBA: More Business Acumen’ Course, 8th-12th December 2019In 2015, 35% of employers in engineering and technology-based business s...
Data-driven design and the opportunities it presents for biotech companies
Professor Paul Freemont, Co-Director of SynbiCITE, discussed the synthetic biology industry and the opportunities it is creating in a recently paper published in The Emerging Topics in Life Sciences entitled “Synthetic biology industry: data-driven design is creating new opportunities in biotechnology”.
The Cell Factories of the Future
Professor Paul Freemont, Co-Director of SynbiCITE, is the lead author of a recent article published by the World Economic Forum on this subject, entitled “How scientists are turning living cells into the tiny factories of the future”.